There is now a REDCap e-consent Framework that is 21 CFR Part 11 compliant. You can use this new REDCap e-consent Framework to obtain electronic consent from research participants enrolling in FDA regulated studies. FDA-regulated studies investigate a drug, medical device or biologic.

Suhrud Rajguru, Ph.D., has joined the CTSI’s Translational Workforce Development Program as its new Co-Director. Dr. Rajguru will lead the program with fellow Co-Directors Tatjana Rundek, M.D., Ph.D., and Alessia Fornoni, M.D., Ph.D.

Miami CTSI Associate Director Jonelle E. Wright, Ph.D., DPNAP, who was instrumental in securing the University’s first NIH-funded Clinical and Translational Science Award in 2012 and its subsequent renewal award, is retiring and will transition to a Voluntary Faculty appointment. In her leadership role, Dr. Wright helped to advance the CTSI as a dynamic force for clinical and translational science across the University and beyond. Read her farewell message to the CTSI community.